Back to mobile site

Skystar Bio Pharmaceutical Co. (SKBI) Reports Q1 EPS of $0.09

May 16, 2013 6:30 AM EDT
Skystar Bio Pharmaceutical Co. (NASDAQ: SKBI) reported Q1 EPS of $0.09, versus $0.26 reported last year. Revenue for the quarter came in at $5.53 million, versus $7.93 million reported last year.

For earnings history and earnings-related data on Skystar Bio Pharmaceutical Co. (SKBI) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings